These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20550773)

  • 1. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis.
    He GX; van den Hof S; Borgdorff MW; van der Werf MJ; Cheng SM; Hu YL; Zhang LX; Wang LX
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):884-9. PubMed ID: 20550773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.
    Simpson G; Coulter C; Weston J; Knight T; Carter R; Vincent S; Robertus L; Konstantinos A
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):551-2. PubMed ID: 21396218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of drug-resistant tuberculosis.
    Chiang CY; Schaaf HS
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W; Harries AD; Hinderaker SG
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
    Gler MT; Macalintal LE; Raymond L; Guilatco R; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2011 May; 15(5):652-6. PubMed ID: 21756517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.